Results 1 to 10 of about 1,324,041 (317)

Use and Outcomes of Medication for Opioid Use Disorder Among Patients With Opioid Use Disorder Undergoing Surgery [PDF]

Annals of Surgery Open
Objective:. We examined patterns of use of perioperative medication for opioid use disorder (MOUD) in patients undergoing surgical procedures and assessed the association between MOUD use and perioperative opioid use and postsurgical adverse events ...
Alicia H. Li, MD, Yongmei Huang, MD, DrPH, Silvia S. Martins, MD, PhD, Yukio Suzuki, MD, PhD, Jennifer S. Ferris, PhD, Xiao Xu, PhD, Dawn L. Hershman, MD, Jason D. Wright, MD   +7 more
doaj   +2 more sources

Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021

JAMA Network Open, 2023
This cross-sectional study uses data from the 2021 National Survey on Drug Use and Health to estimate the receipt of medication for opioid use disorder among US adults with past-year opioid use disorder.
Christopher M. Jones, B. Han, G. Baldwin, Emily B. Einstein, W. Compton   +4 more
semanticscholar   +1 more source

Comorbid Opioid Use Disorder in Body Dysmorphic Disorder

European Psychiatry, 2022
Introduction Body Dysmorphic Disorder (BDD) is a severe and common disorder that consists of distressing or impairing preoccupation with nonexistent or slight flaws in one’s physical appearance.
J. Kim, O. Alli-Balogun, G. Gill, P. Korenis, S. Mitra   +4 more
doaj   +1 more source

Racial Inequality in Receipt of Medications for Opioid Use Disorder.

New England Journal of Medicine, 2023
BACKGROUND Since 2010, Black persons in the United States have had a greater increase in opioid overdose-related mortality than other groups, but national-level evidence characterizing racial and ethnic disparities in the use of medications for opioid ...
Michael L. Barnett, E. Meara, Terri Lewinson, Brianna Hardy, Deanna Chyn, Moraa Onsando, H. Huskamp, A. Mehrotra, N. Morden   +8 more
semanticscholar   +1 more source

Attending a Biopsychosocially Focused Buprenorphine Training Improves Clinician Attitudes

Frontiers in Psychiatry, 2021
Objective: Substance use disorders remain highly stigmatized. Access to medications for opioid use disorder is poor. There are many barriers to expanding access including stigma and lack of medical education about substance use disorders. We enriched the
Holly Ann Russell, Brian Smith, Mechelle Sanders, Elizabeth Loomis   +3 more
doaj   +1 more source

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl

JAMA Network Open, 2023
Key Points Question Are higher doses of buprenorphine treatment for opioid use disorder associated with improved retention in treatment when use of fentanyl (vs heroin) is more prevalent?
Laura C. Chambers, Benjamin D Hallowell, Andrew R. Zullo, Taylor J. Paiva, J. Berk, Rachel Gaither, Aidan J. Hampson, Francesca L. Beaudoin, Rachel S. Wightman   +8 more
semanticscholar   +1 more source

Prevalence and predictors of suicidality among adults initiating office-based buprenorphine

Addiction Science & Clinical Practice, 2023
Background Individuals who have substance use disorders may have an elevated risk of suicidality. This study sought to examine the prevalence of, and identify factors associated with, suicidality in adults with opioid use disorder (OUD) initiating office-
Michelle R. Lent, Karen L. Dugosh, Emily Hurstak, Hannah R. Callahan, Kimberly Mazur, The Greater Philadelphia Opioid Use Disorder Research Group   +5 more
doaj   +1 more source

Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic

JAMA Network Open, 2023
This cohort study assesses the level of telehealth implementation and its outcomes among office-based clinicians who provide outpatient opioid use disorder care.
Ruth Hailu, A. Mehrotra, H. Huskamp, Alisa B. Busch, Michael L. Barnett   +4 more
semanticscholar   +1 more source

Patient evaluation of a smartphone application for telehealth care of opioid use disorder

Addiction Science & Clinical Practice, 2022
Background People with opioid use disorder (OUD) face barriers to entering and remaining in life-saving treatment (e.g., stigma, detrimental interactions with health care, and privacy concerns).
Jordon D. Bosse, Kim Hoffman, Katharina Wiest, P. Todd Korthuis, Ritwika Petluri, Kellie Pertl, Stephen A. Martin   +6 more
doaj   +1 more source

ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids.

Journal of addiction medicine, 2023
Treatment of opioid use disorder (OUD) with buprenorphine has evolved considerably in the last decade as the scale of the OUD epidemic has increased along with the emergence of high-potency synthetic opioids (HPSOs) and stimulants in the drug supply ...
M. Weimer, A. Herring, S. S. Kawasaki, M. Meyer, Bethea A. Kleykamp, Kelly S Ramsey   +5 more
semanticscholar   +1 more source